Randy Gregory Sues NFL for Disability Discrimination

In a pivotal clash of legal interpretations, former Denver Broncos linebacker Randy Gregory has initiated a lawsuit against the National Football League (NFL) and the Denver Broncos, claiming disability discrimination. This groundbreaking legal action is anchored in Gregory’s request to the league to allow him to use dronabinol, a synthetic THC formulation prescribed by his physician. Struggling with significant health conditions such as social anxiety disorder, PTSD, and chronic pain, Gregory’s use of this medication is at the crux of the controversy. According to Gregory, his sincere efforts to provide the necessary medical documentation and to engage in dialogue have been met with resistance by the NFL. His request for a therapeutic use exemption was denied, despite dronabinol being recognized as essential for his treatment. Consequently, Gregory was fined more than half a million dollars for his positive THC drug tests, a sum that not only weighs heavily on his finances but also carries implications for his professional future.

A Clash with the NFL

At the center of this legal dispute is the NFL’s stance on dronabinol, which remains a federally controlled substance. This position has forced Gregory to confront the punitive measures of the league’s drug policy head-on. The controversy reflects broader issues related to workplace accommodations for disabilities, pitting the evolving landscape of medical treatment against rigid employer policies. Gregory is leveraging the Colorado Anti-Discrimination Act (CADA), which concurs with the Americans with Disabilities Act (ADA), positing that his exemption request was both reasonable and crucial for managing his debilitating conditions. His legal action raises pressing questions about the extent to which employers, such as the NFL, are required to accommodate the medical needs of employees, especially when treatment entails controlled substances.

Precedents and Implications

Ex-Denver Broncos linebacker Randy Gregory has taken a legal swing at the NFL and his former team, invoking claims of disability discrimination. The lawsuit stems from his plea to the league to approve the use of dronabinol, a synthetic form of THC, which his doctor prescribed for his considerable health issues, including social anxiety, PTSD, and chronic pain. Gregory has faced a standoff with the NFL, who rebuffed his appeals for a therapeutic use exemption and penalized him over $500,000 for testing positive for THC. Gregory argues that this medication is critical for his treatment, yet the NFL’s rejection not only impacts his bank account but also his career trajectory. Gregory’s fight highlights a battle over medical autonomy and the NFL’s substance policies, posing significant repercussions for the player’s financial and professional standing. The conflict sheds light on the broader issues of player health management and the evolving conversation around cannabis-based treatments in sports.

Explore more

How Can AI and CRM Architecture Drive Small Business Growth?

Navigating the complexities of the modern commercial landscape requires more than just grit and a good product because the sheer volume of digital signals generated by every customer interaction can quickly drown an unprepared entrepreneur. In the current market, the difference between a thriving enterprise and a stagnant one often comes down to how effectively a company manages its invisible

Canadian HR Leaders Unlock Strategic Value in Payroll Analytics

Hidden deep within the digital spreadsheets of every major Canadian corporation lies a sleeping giant of data that could fundamentally reshape the future of the modern workforce if only leaders knew how to wake it up. While most organizations view the biweekly distribution of funds as a repetitive administrative burden, forward-thinking Human Resources executives are beginning to see these transactions

Modern Marketing Automation Tools for Small Business Growth

Success in the current high-velocity marketplace is no longer defined by how many hours a founder works, but rather by how effectively they can delegate the mundane to sophisticated digital systems. Small business owners frequently find themselves trapped in a repetitive cycle of manual administrative tasks that ultimately stifle creative and strategic growth. With the modern marketplace demanding instant responses

How Does Event-Driven Marketing Solve Two-Way Messaging?

When a customer types the word “STOP” into a mobile messaging thread only to receive a promotional discount code three seconds later, the resulting frustration erodes years of brand loyalty in a single heartbeat. This specific moment of failure highlights the fundamental gap between the promise of modern customer engagement and the reality of legacy infrastructure. In 2026, where instant

How Will AI Integration Reshape B2B Marketing Budgets by 2027?

The Strategic Shift Toward an AI-Driven Financial Landscape The traditional boundaries of B2B marketing are dissolving as organizations reallocate massive amounts of capital toward integrated artificial intelligence systems that promise unprecedented scale. While many early adopters once viewed these technologies as simple shortcuts to lower overhead, the reality in 2026 is that AI is driving a profound redistribution of resources

Fill out the form below